Hippocampal Glycogen Synthase Kinase 3β is Critical for the Antidepressant Effect of Cyclin-Dependent Kinase 5 Inhibitor in Rats
- 22 February 2014
- journal article
- research article
- Published by Springer Nature in Journal of Molecular Neuroscience
- Vol. 54 (1) , 92-99
Abstract
Cdk5 is a member of cyclin-dependent kinase (Cdk), a proline-directed serine/threonine kinase, and plays a key role in normal neural development and function. Evidence of previous study showed that chronic inhibition of Cdk5 in hippocampal dentate gyrus (DG) blocked the development of depressive-like symptoms, suggesting that Cdk5 plays a role in development of depression. Forced swim test, novelty-suppressed feeding test, and learned helplessness were used to evaluate the cellular and molecular mechanisms underlying the behavioral regulation of Cdk5 inhibitors in rats. Two Cdk5 inhibitors butyrolactone and roscovitine were used to investigate the possible antidepressant-like actions of Cdk5 blockade and the potential mechanisms. Systemic administration of butyrolactone (200 mg/kg, IP) or roscovitine (100 mg/kg, IP) produced effective antidepressant-like actions. Moreover, infusion (5 mM) of GSK3β activator LY294002 into DG abolished the antidepressant-like actions of butyrolactone and roscovitine, suggesting that inhibition of GSK3β might be involved in the antidepressant effect of Cdk5 inhibitors. Moreover, pretreatment of LY294002 (5 mM) blocked the antidepressant-like effect of butyrolactone and roscovitine in learned helplessness. Additionally, inescapable footshock induced a significant increase of GSK3β activity, while butyrolactone and roscovitine decreased GSK3β activity. In contrast, pretreatment of LY294002 prevented the inhibitory effects of butyrolactone and roscovitine on GSK3β activation. Finally, a specific GSK3β inhibitor, SB216763 (1 ng, DG), demonstrated an effective antidepressant-like action. These findings demonstrate that systemic administration of Cdk5 inhibitors produced antidepressant-like actions and that inhibition of GSK3β is involved in behavioral response of Cdk5 inhibitors.Keywords
This publication has 53 references indexed in Scilit:
- Neuritin produces antidepressant actions and blocks the neuronal and behavioral deficits caused by chronic stressProceedings of the National Academy of Sciences, 2012
- Wnt2 Expression and Signaling Is Increased by Different Classes of Antidepressant TreatmentsBiological Psychiatry, 2010
- Dopamine D1 receptor activation induces tau phosphorylation via cdk5 and GSK3 signaling pathwaysNeuropharmacology, 2009
- Disrupted in Schizophrenia 1 Regulates Neuronal Progenitor Proliferation via Modulation of GSK3β/β-Catenin SignalingCell, 2009
- Remodeling of Hippocampal Spine Synapses in the Rat Learned Helplessness Model of DepressionBiological Psychiatry, 2009
- Stress, Depression, and Neuroplasticity: A Convergence of MechanismsNeuropsychopharmacology, 2007
- Development of Polycystic Kidney Disease in Juvenile Cystic Kidney MiceJournal of the American Society of Nephrology, 2006
- Opposing Roles of Transient and Prolonged Expression of p25 in Synaptic Plasticity and Hippocampus-Dependent MemoryNeuron, 2005
- Neuroplasticity: from MRI to depressive symptomsEuropean Neuropsychopharmacology, 2004
- Cdk5 is essential for synaptic vesicle endocytosisNature Cell Biology, 2003